Clincosm LogoSign in Get a demo

advanced prostate cancer

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

Not yet recruiting
  • Advanced Prostate Cancer
  • Lyon, France
  • +2 more
Oct 18, 2023

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Advanced Prostate Cancer Trial (HRS-4357 injection)

Not yet recruiting
  • Advanced Prostate Cancer
  • HRS-4357 injection
  • (no location specified)
Aug 16, 2023

Advanced Prostate Cancer Trial (HRS-5041)

Not yet recruiting
  • Advanced Prostate Cancer
  • (no location specified)
Jul 5, 2023

Advanced Prostate Cancer, Metastatic Prostate Cancer Trial (RO7656594)

Not yet recruiting
  • Advanced Prostate Cancer
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 24, 2023

Advanced Prostate Cancer Trial in United Kingdom, United States (HPN424)

Active, not recruiting
  • Advanced Prostate Cancer
  • HPN424 In Part 1 (Dose Escalation)
  • HPN424 In Part 2 (Dose Expansion)
  • Los Angeles, California
  • +14 more
Jan 20, 2023

Advanced Prostate Cancer, Metastatic Prostate Cancer, Locally Advanced Prostate Cancer Trial in China (Triptorelin pamoate

Recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Triptorelin pamoate (embonate) salt
  • Beijing, China
  • +24 more
Jan 17, 2023

Advanced Metastatic Cancer, Advanced Prostate Cancer Trial in United States (Nivolumab Monotherapy, Nivolumab and Ipilimumab and

Active, not recruiting
  • Advanced Metastatic Cancer
  • Advanced Prostate Cancer
  • Nivolumab Monotherapy
  • +3 more
  • Los Angeles, California
  • +5 more
Dec 16, 2022

Advanced Prostate Cancer Trial in Visakhapatnam (Inj. Goserelin (Test) Subcutaneously, Inj. Zoladex (Reference) Subcutaneously)

Recruiting
  • Advanced Prostate Cancer
  • Inj. Goserelin (Test) Subcutaneously
  • Inj. Zoladex (Reference) Subcutaneously
  • Visakhapatnam, Andhra Pradesh, India
    Mahatma Gandhi Cancer Hospital & Research Institute
Nov 29, 2022

Advanced Prostate Cancer Trial in Hong Kong (Conventional IMRT, SBRT)

Recruiting
  • Advanced Prostate Cancer
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Sep 13, 2022

Advanced Prostate Cancer Trial in Baltimore (Pelvic DCFPyL PET-MRI fusion or PET/MRI)

Recruiting
  • Advanced Prostate Cancer
  • Pelvic DCFPyL PET-MRI fusion or PET/MRI
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 22, 2022

Whole Body Magnetic Resonance Imaging Study

Active, not recruiting
  • Advanced Prostate Cancer
  • WB-MRI
  • Sutton, Surrey, United Kingdom
    The Royal Marsden NHS Foundation Trust
May 18, 2021

PROSABI: Prospective Multi-centre Study of Prognostic Factors in

Unknown status
  • Advanced Prostate Cancer
  • Abiraterone ACetate
    • Ferrol, A Coruña, Spain
    • +23 more
    Jan 23, 2020

    PROSENZA: Prospective Multi-Centre Study of Prognostic Factors

    Unknown status
    • Advanced Prostate Cancer
    • +2 more
      • Ferrol, A Coruña, Spain
      • +25 more
      Jan 23, 2020

      PROSTAC: Prospective Multi-centre Study of Prognostic Factors in

      Unknown status
      • Advanced Prostate Cancer
      • +2 more
        • Santiago de Compostela, A Coruña, Spain
        • +24 more
        Jan 23, 2020

        PRORADIUM: Prospective Multi-centre Study of Prognostic Factors

        Unknown status
        • Advanced Prostate Cancer
        • +2 more
        • Radium 223 55mBq/Kg every 4 weeks intravenously
        • Ferrol, A Coruña, Spain
        • +62 more
        Jan 23, 2020

        Hormone Naïve Prostate Cancer and Without Comorbidities Treated

        Completed
        • Advanced Prostate Cancer
        • Degarelix
        • LHRH agonist (Leuprorelinacetat, Goserelinacetat, Buserelinacetat, Triptorelinacetat)
        • Rottweil, Germany
          Investigational site (there may be other sites in this country)
        Jul 1, 2019

        Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

        Completed
        Has Results
        • Advanced Prostate Cancer
        • Prostatic Neoplasms
        • sipuleucel-T
        • Bessemer, Alabama
        • +332 more
        Mar 5, 2019

        Cohort in Patients With Advanced Prostate Cancer

        Completed
        • Advanced Prostate Cancer
          • Fredericia, Denmark
          • +34 more
          Jan 11, 2019

          Advanced Prostate Cancer, Lower Urinary Tract Symptoms, Quality of Life Trial (Surgery combinate with Endocrine therapy,

          Not yet recruiting
          • Advanced Prostate Cancer
          • +4 more
          • Surgery combinate with Endocrine therapy
          • Endocrine therapy
          • (no location specified)
          Oct 8, 2018

          Advanced Prostate Cancer Trial in Ft. Myers, Omaha, Nashville (BKM 120, Cabazitaxel)

          Withdrawn
          • Advanced Prostate Cancer
          • Ft. Myers, Florida
          • +2 more
          Feb 10, 2016

          Lucrin® Depot Efficacy and Safety Monitoring Study in Advanced

          Completed
          Has Results
          • Advanced Prostate Cancer
          • Lower Urinary Tract Symptoms
          • Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine)
          • Belchatow, Poland
          • +142 more
          Jan 12, 2012

          Advanced Prostate Cancer Trial in Italy (Docetaxel + LH-RH analogues, Docetaxel, Continuous Docetaxel)

          Unknown status
          • Advanced Prostate Cancer
          • Docetaxel + LH-RH analogues
          • +2 more
          • Saluzzo, Cuneo, Italy
          • +31 more
          Oct 19, 2010

          Prostate-Specific Antigen Levels in Advanced Prostate Cancer

          Completed
          • Advanced Prostate Cancer
            • Cakovec, Croatia
            • +14 more
            Apr 14, 2010